Find in Library

P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH MELFLUFEN AND DEXAMETHASONE (DEX) OR POMALIDOMIDE (POM) AND DEX: ANALYSES FROM THE PHASE 3 OCEAN STUDY

oleh: F Schjesvold, H Ludwig, S Delimpasi, P Robak, M Mateos, A Sandberg, M Thuresson, S Norin, P Richardson, P Sonneveld